SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041762
Filing Date
2023-08-11
Accepted
2023-08-11 14:20:54
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-20230630.htm   iXBRL 10-Q 2601774
2 EX-31.1 isco-ex31_1.htm EX-31.1 15729
3 EX-31.2 isco-ex31_2.htm EX-31.2 15592
4 EX-32.1 isco-ex32_1.htm EX-32.1 10141
5 EX-32.2 isco-ex32_2.htm EX-32.2 10784
  Complete submission text file 0000950170-23-041762.txt   11571148

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isco-20230630.xsd EX-101.SCH 60046
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isco-20230630_cal.xml EX-101.CAL 50514
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isco-20230630_pre.xml EX-101.PRE 334996
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isco-20230630_def.xml EX-101.DEF 202157
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isco-20230630_lab.xml EX-101.LAB 447107
65 EXTRACTED XBRL INSTANCE DOCUMENT isco-20230630_htm.xml XML 2957553
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 231163167
SIC: 2834 Pharmaceutical Preparations